123 related articles for article (PubMed ID: 22654325)
1. Prospective randomised controlled trial comparing sub-epididymal orchiectomy versus conventional orchiectomy in metastatic carcinoma of prostate.
Bapat S; Mahajan PM; Bhave AA; Kshirsagar YB; Sovani YB; Mulay A
Indian J Surg; 2011 Jun; 73(3):175-7. PubMed ID: 22654325
[TBL] [Abstract][Full Text] [Related]
2. Epididymal sparing bilateral simple orchiectomy with epididymoplasty: preservation of esthetics and body image.
Issa MM; Lendvay TS; Bouet R; Young MR; Petros JA; Marshall FF
J Urol; 2005 Sep; 174(3):893-7. PubMed ID: 16093982
[TBL] [Abstract][Full Text] [Related]
3. Can Subepididymal Orchiectomy Re-emerge as the Treatment of Choice in Patients with Advanced Prostatic Carcinoma?
Agarwal M; Agrawal MS
Indian J Surg; 2015 Feb; 77(1):23-7. PubMed ID: 25829707
[TBL] [Abstract][Full Text] [Related]
4. Satisfaction and genital perception after orchiectomy for prostate cancer: does the technique matter? A randomized trial.
Singh O; Mukherjee P; Sakthivel MS; Wann C; George AJP; Gopalakrishnan R; Antonisamy B; Devasia A; Kumar S; Kekre NS; Chandrasingh J
Int Urol Nephrol; 2021 Aug; 53(8):1583-1589. PubMed ID: 33851360
[TBL] [Abstract][Full Text] [Related]
5. Epididymal Sparing Bilateral Simple Orchiectomy: Cost-Effectiveness and Aesthetic Preservation for Men with Metastatic Prostate Cancer.
Weinberg AE; Liu JJ; Sandelien M; Waite N; Reese JH
Urol Pract; 2016 Mar; 3(2):112-117. PubMed ID: 37592511
[TBL] [Abstract][Full Text] [Related]
6. Cosmetic orchiectomy using pedicled fibro-fatty tissue graft for prostate cancer: a new approach.
Kihara K; Oshima H
Eur Urol; 1998 Sep; 34(3):210-5. PubMed ID: 9732195
[TBL] [Abstract][Full Text] [Related]
7. [Application of scrotoscope in the diagnosis and treatment of testicular and epididymal diseases].
Yin Z; Yang JR; Wang Z; Wei YB; Yan B; Zhou KQ
Beijing Da Xue Xue Bao Yi Xue Ban; 2015 Aug; 47(4):648-52. PubMed ID: 26284403
[TBL] [Abstract][Full Text] [Related]
8. Clinical presentation, management and follow-up of 83 patients with Leydig cell tumors of the testis: a prospective case-cohort study.
Pozza C; Pofi R; Tenuta M; Tarsitano MG; Sbardella E; Fattorini G; Cantisani V; Lenzi A; Isidori AM; Gianfrilli D;
Hum Reprod; 2019 Aug; 34(8):1389-1403. PubMed ID: 31532522
[TBL] [Abstract][Full Text] [Related]
9. Clamp ablation of the testes compared to bilateral orchiectomy as androgen deprivation therapy for advanced prostate cancer.
Zarrabi AD; Heyns CF
Int Braz J Urol; 2011; 37(3):347-54; discussion 354. PubMed ID: 21756382
[TBL] [Abstract][Full Text] [Related]
10. Autologous tunica vaginalis and subcapsular orchiectomy: a hormonal therapy for prostate cancer.
Vickers MA; Lamontagne DP; Guru KA; Satyanarayana RK; Vickers KE; Menon M
J Androl; 2004; 25(3):375-81. PubMed ID: 15064315
[TBL] [Abstract][Full Text] [Related]
11. Health-related quality of life after apalutamide treatment in patients with metastatic castration-sensitive prostate cancer (TITAN): a randomised, placebo-controlled, phase 3 study.
Agarwal N; McQuarrie K; Bjartell A; Chowdhury S; Pereira de Santana Gomes AJ; Chung BH; Özgüroğlu M; Juárez Soto Á; Merseburger AS; Uemura H; Ye D; Given R; Cella D; Basch E; Miladinovic B; Dearden L; Deprince K; Naini V; Lopez-Gitlitz A; Chi KN;
Lancet Oncol; 2019 Nov; 20(11):1518-1530. PubMed ID: 31578173
[TBL] [Abstract][Full Text] [Related]
12. Subcapsular orchiectomy versus total orchiectomy and LHRH analogue in the treatment of hormone-sensitive metastatic prostate cancer: a different perspective in evaluation of the psychosocial effects.
Selvi I; Basar H
Support Care Cancer; 2020 Sep; 28(9):4313-4326. PubMed ID: 31912363
[TBL] [Abstract][Full Text] [Related]
13. The time for serum testosterone to reach castrate level after bilateral orchiectomy or oral estrogen in the management of metastatic prostatic cancer.
Lin BJ; Chen KK; Chen MT; Chang LS
Urology; 1994 Jun; 43(6):834-7. PubMed ID: 8197647
[TBL] [Abstract][Full Text] [Related]
14. Redefining clinically significant castration levels in patients with prostate cancer receiving continuous androgen deprivation therapy.
Morote J; Orsola A; Planas J; Trilla E; Raventós CX; Cecchini L; Catalán R
J Urol; 2007 Oct; 178(4 Pt 1):1290-5. PubMed ID: 17698136
[TBL] [Abstract][Full Text] [Related]
15. [Multicentre randomized trial comparing triptorelin medical castration versus surgical castration in the treatment of locally advanced or metastatic prostate cancer].
Botto H; Rouprêt M; Mathieu F; Richard F
Prog Urol; 2007 Apr; 17(2):235-9. PubMed ID: 17489325
[TBL] [Abstract][Full Text] [Related]
16. Comparison of subcapsular and total orchiectomy for treatment of metastatic prostate cancer.
Zhang XZ; Donovan MP; Williams BT; Mohler JL
Urology; 1996 Mar; 47(3):402-4. PubMed ID: 8633409
[TBL] [Abstract][Full Text] [Related]
17. Prostatic adenocarcinoma presenting with metastases to the testis and epididymis: A case report.
Zhang J; Dong M; Hu X; Liu L; Li S; Li C; Yang L; Xiao Y; Pang S; Wang C
Oncol Lett; 2016 Jan; 11(1):792-794. PubMed ID: 26870285
[TBL] [Abstract][Full Text] [Related]
18. Diverse secretory patterns of clusterin by epididymis and prostate/seminal vesicles undergoing cell regression after orchiectomy.
Grima J; Zwain I; Lockshin RA; Bardin CW; Cheng CY
Endocrinology; 1990 Jun; 126(6):2989-97. PubMed ID: 2351105
[TBL] [Abstract][Full Text] [Related]
19. Combined androgen blockade in the management of advanced prostate cancer: a sensible or ostensible approach.
Ansari MS; Gupta NP; Hemal AK; Dogra PN; Seth A
Int J Urol; 2004 Dec; 11(12):1092-6. PubMed ID: 15663681
[TBL] [Abstract][Full Text] [Related]
20. Efficacy of Intratesticular Glycerol Injection as Male Cat Contraception in Comparison with Two Surgical Approaches.
Madbouly H; Korany R; El-Shahat K; Eissa H; Fathi M
Top Companion Anim Med; 2021 Mar; 42():100493. PubMed ID: 33152526
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
